IDO1 and neoplasm: Given the mouting evidence that high IDO expression can lead to inhibition of the effector function of T cells, either directly or indirectly through non-T cell components36,37, strategies to effectively target this metabolic pathway can reverse tumor immune resistance mechanisms.